Brachytherapy planning, cervical malignancy PELVIS:UTERUS, ADNEXA: Intrauterine linear structure related to therapy receipt. Interval improvement in size of heterogeneous cervical mass, measuring 2.8 x 1.6 cm, image 27 series 501, remeasured and previously measured 3.7 x 2.9 cm. Improvement in degree of extension into uterus and improved adjacent soft tissue stranding/parametrial invasion. Corresponding postcontrast arterial enhancement no longer delineated. Stable to minimal interval decrease in size of right adnexal lesion, may reflect patient's normal ovary but nonspecific, measuring 4 x 2.5 cm, image 44 series 501, previously measured 4.4 x 2.8 cm. Presumed left ovary on image 414 series 1204, stable in appearance. ABLADDER: No significant abnormality noted.LYMPH NODES: Reference left pelvic sidewall lymph node demonstrates interval decrease in size, measuring 0.8 x 0.6 cm, image 394 series 1204, previously measured 1.4 x 1 cm.BOWEL, MESENTERY: Mild circumferential rectosigmoid colon wall thickening.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1. Decreased size of heterogeneous cervical mass. Improvement in degree of extension into uterus and improved adjacent soft tissue stranding/parametrial invasion. Stable to minimal interval decrease in size of right adnexal lesion, may reflect patient's normal ovary but nonspecific, may be further assessed with dedicated pelvic sonography. 2. Decreased size of reference left pelvic side wall lymph node.